Previous Close | 87.66 |
Open | 0.00 |
Bid | 85.88 x 0 |
Ask | 86.86 x 0 |
Day's Range | 0.00 - 0.00 |
52 Week Range | |
Volume | |
Avg. Volume | 5,853 |
Market Cap | 1.759T |
Beta (5Y Monthly) | 0.40 |
PE Ratio (TTM) | 143.52 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 1.39 (1.61%) |
Ex-Dividend Date | Jun 14, 2024 |
1y Target Est | N/A |
NORTHAMPTON, MA / ACCESSWIRE / June 12, 2024 / Merck & Co., Inc.Strong career paths and cutting-edge science draw more women scientists - like chemists and engineers - to the company's small molecule process R&D team Women scientists have historically ...
The company's scientists are accelerating research by looking to improve anti-tumor immune response, targeting specific cancer cells and helping inhibit cancer growth NORTHAMPTON, MA / ACCESSWIRE / June 6, 2024 / In recent decades, our improved understanding ...
RAHWAY, N.J., June 05, 2024--Merck to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference